Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FHP9E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,233
Award facts
- Contract value 100% obligated
- $25,232.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,232.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a non-set-aside competitive award with an ultimate completion date of November 4, 2025, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through competitive procurement processes, with delivery orders typically structured on firm fixed-price terms ranging from minimal to substantial order values. This award supports DLA's ongoing pharmaceutical supply chain operations for military and defense-related healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FHP9E?
SPE2DR26FHP9E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FHP9E worth?
The government has obligated $25,233 on SPE2DR26FHP9E.
Is contract SPE2DR26FHP9E an order under another contract?
Yes. SPE2DR26FHP9E is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHP9E competed?
The extent of competition for SPE2DR26FHP9E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award